RF-A089

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRF-A089
Drug Alias NameRF-A089
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnaplastic lymphoma kinase inhibitors
TargetsAnaplastic lymphoma kinase
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHubei Bio-Pharmaceutical Industrial Technological Institute IncHumanwell Healthcare (Group) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHubei Bio-Pharmaceutical Industrial Technological Institute IncHumanwell Healthcare (Group) Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A